Annual CFI
$64.16 M
-$4.20 M-6.14%
December 31, 2024
Summary
- As of March 10, 2025, IGMS annual cash flow from investing activities is $64.16 million, with the most recent change of -$4.20 million (-6.14%) on December 31, 2024.
- During the last 3 years, IGMS annual CFI has risen by +$48.70 million (+314.97%).
- IGMS annual CFI is now -6.14% below its all-time high of $68.36 million, reached on December 31, 2023.
Performance
IGMS Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$18.00 M
+$5.01 M+38.59%
December 31, 2024
Summary
- As of March 10, 2025, IGMS quarterly cash flow from investing activities is $18.00 million, with the most recent change of +$5.01 million (+38.59%) on December 31, 2024.
- Over the past year, IGMS quarterly CFI has stayed the same.
- IGMS quarterly CFI is now -74.23% below its all-time high of $69.82 million, reached on March 31, 2023.
Performance
IGMS Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$64.16 M
+$32.69 M+103.88%
December 31, 2024
Summary
- As of March 10, 2025, IGMS TTM cash flow from investing activities is $64.16 million, with the most recent change of +$32.69 million (+103.88%) on December 31, 2024.
- Over the past year, IGMS TTM CFI has stayed the same.
- IGMS TTM CFI is now -31.05% below its all-time high of $93.04 million, reached on June 30, 2021.
Performance
IGMS TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
IGMS Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -6.1% | 0.0% | 0.0% |
| 3 y3 years | +315.0% | 0.0% | 0.0% |
| 5 y5 years | +131.6% | 0.0% | 0.0% |
IGMS Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -6.1% | +128.4% | -74.2% | +109.8% | -6.1% | +125.9% |
| 5 y | 5-year | -6.1% | +128.4% | -74.2% | +109.8% | -31.1% | +125.9% |
| alltime | all time | -6.1% | +128.4% | -74.2% | +109.8% | -31.1% | +125.9% |
IGM Biosciences Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $64.16 M(-6.1%) | $18.00 M(+38.6%) | $64.16 M(+103.9%) |
| Sep 2024 | - | $12.99 M(-47.0%) | $31.47 M(-17.3%) |
| Jun 2024 | - | $24.52 M(+183.5%) | $38.03 M(+429.5%) |
| Mar 2024 | - | $8.65 M(-158.9%) | $7.18 M(-89.5%) |
| Dec 2023 | $68.36 M(-130.3%) | -$14.69 M(-175.2%) | $68.36 M(+6.4%) |
| Sep 2023 | - | $19.55 M(-409.1%) | $64.24 M(+56.9%) |
| Jun 2023 | - | -$6.33 M(-109.1%) | $40.94 M(-129.9%) |
| Mar 2023 | - | $69.82 M(-471.2%) | -$136.72 M(-39.4%) |
| Dec 2022 | -$225.64 M(-1559.4%) | -$18.81 M(+401.9%) | -$225.64 M(+10.3%) |
| Sep 2022 | - | -$3.75 M(-98.0%) | -$204.59 M(-17.5%) |
| Jun 2022 | - | -$183.98 M(+863.1%) | -$247.96 M(+473.3%) |
| Mar 2022 | - | -$19.10 M(-952.8%) | -$43.25 M(-379.8%) |
| Dec 2021 | $15.46 M | $2.24 M(-104.8%) | $15.46 M(-55.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | -$47.11 M(-327.4%) | $34.45 M(-63.0%) |
| Jun 2021 | - | $20.72 M(-47.7%) | $93.04 M(+34.1%) |
| Mar 2021 | - | $39.61 M(+86.6%) | $69.37 M(+19.0%) |
| Dec 2020 | $58.29 M(-128.7%) | $21.23 M(+84.8%) | $58.29 M(-154.6%) |
| Sep 2020 | - | $11.48 M(-488.9%) | -$106.67 M(-39.6%) |
| Jun 2020 | - | -$2.95 M(-110.4%) | -$176.51 M(+1.4%) |
| Mar 2020 | - | $28.53 M(-119.8%) | -$173.99 M(-14.4%) |
| Dec 2019 | -$203.24 M(>+9900.0%) | -$143.73 M(+146.3%) | -$203.24 M(+241.5%) |
| Sep 2019 | - | -$58.36 M(>+9900.0%) | -$59.51 M(+5083.9%) |
| Jun 2019 | - | -$433.00 K(-39.4%) | -$1.15 M(+60.6%) |
| Mar 2019 | - | -$715.00 K | -$715.00 K |
| Dec 2018 | -$788.00 K(+104.7%) | - | - |
| Dec 2017 | -$385.00 K | - | - |
FAQ
- What is IGM Biosciences annual cash flow from investing activities?
- What is the all time high annual CFI for IGM Biosciences?
- What is IGM Biosciences annual CFI year-on-year change?
- What is IGM Biosciences quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for IGM Biosciences?
- What is IGM Biosciences quarterly CFI year-on-year change?
- What is IGM Biosciences TTM cash flow from investing activities?
- What is the all time high TTM CFI for IGM Biosciences?
- What is IGM Biosciences TTM CFI year-on-year change?
What is IGM Biosciences annual cash flow from investing activities?
The current annual CFI of IGMS is $64.16 M
What is the all time high annual CFI for IGM Biosciences?
IGM Biosciences all-time high annual cash flow from investing activities is $68.36 M
What is IGM Biosciences annual CFI year-on-year change?
Over the past year, IGMS annual cash flow from investing activities has changed by -$4.20 M (-6.14%)
What is IGM Biosciences quarterly cash flow from investing activities?
The current quarterly CFI of IGMS is $18.00 M
What is the all time high quarterly CFI for IGM Biosciences?
IGM Biosciences all-time high quarterly cash flow from investing activities is $69.82 M
What is IGM Biosciences quarterly CFI year-on-year change?
Over the past year, IGMS quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is IGM Biosciences TTM cash flow from investing activities?
The current TTM CFI of IGMS is $64.16 M
What is the all time high TTM CFI for IGM Biosciences?
IGM Biosciences all-time high TTM cash flow from investing activities is $93.04 M
What is IGM Biosciences TTM CFI year-on-year change?
Over the past year, IGMS TTM cash flow from investing activities has changed by $0.00 (0.00%)